Patient clinical and immunophenotypical characteristics of patients with DLBCL, NOS in relation to protein expressions.

Comparison of CD148, CD45 and LCK expression among NC, MD and SV.

Qinghua Nie (147057)
Erin E. Sandford (147062)
Xiquan Zhang (147066)
Lisa K. Nolan (147070)
Susan J. Lamont (114962)

July 2012

(A) CD148. (B) CD45. (C) LCK. NC, MD and SV stand for the groups of non-challenged, challenged-mi...

Comparison of the Expression and Prognostic Significance of Differentiation Markers between Diffuse Large B-Cell Lymphoma of Central Nervous System Origin and Peripheral Nodal Origin

林璟宏
LIN, CHING-HUNG

October 2009

PURPOSE: Whether diffuse large B-cell lymphoma (DLBCL) of primary central nervous system origin (PCN...

Kaplan-Meier survival analysis of DLBCL patients based on independent CXCR7 protein expression or combined CXCR7 and CXCR4 protein expression.

María José Moreno (5420918)
Alberto Gallardo (1943311)
Silvana Novelli (5420921)
Ana Mozos (5420939)
Marc Aragó (5420927)
Miguel Ángel Pavón (5420936)
María Virtudes Céspedes (5420915)
Víctor Pallarès (5420942)
Aïda Falgàs (5420924)
Miguel Alcoceba (3805117)
Oscar Blanco (2286286)
Marcos Gonzalez-Díaz (5420933)
Jorge Sierra (52100)
Ramon Mangues (5420930)
Isolda Casanova (1800304)

June 2018

(A) Patients bearing CXCR7+ tumors showed significantly higher OS than patients bearing CXCR7- tu...

Patient clinical and immunophenotypical characteristics of patients with DLBCL, NOS in relation to DHS and THS.

Li-Xu Yan (223343)
Yan-Hui Liu (203243)
Dong-Lan Luo (608306)
Fen Zhang (608307)
Yu Cheng (136592)
Xin-Lan Luo (608308)
Jie Xu (34477)
Jie Cheng (294193)
Heng-Guo Zhuang (608309)

August 2014

P values were derived using Pearson’s Chi-Square test. Bold font indicates significance.</...

Comparison of clinicopathological features in DLBCL subgroups.

M. Christina Cox (547731)
Arianna Di Napoli (213516)
Stefania Scarpino (547732)
Gerardo Salerno (455832)
Caterina Tatarelli (547733)
Caterina Talerico (547734)
Mariangela Lombardi (547735)
Bruno Monarca (547736)
Sergio Amadori (13541)
Luigi Ruco (213514)

April 2014

p-value1: comparison of clinical features in IgM-secreting and non-secreting DLBCL sub...

Peripheral blood protein profiling in DLBCL

Ask, E

Quantification of 81 proteins in serum or plasma from 19 healthy blood donors and two cohorts of pat...

Meta-analysis of the association between EBER positivity and clinical features in DLBCL patients.

Xiaojuan Gao (4246837)
Jia Li (160557)
Yaqi Wang (1555240)
Shuai Liu (145969)
Baohong Yue (4246840)

June 2018

(A) number of extranodal involvement(>1 vs ≤1); (B) B symptom(presence vs absence); (C) immunohis...

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas

van der Meeren, L E
Kluiver, J
Rutgers, B
Alsagoor, Y
Kluin, P M
van den Berg, A
Visser, L

October 2019

Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...

Clinical characteristics and laboratory findings of analyzed subjects.

Jong-Chan Youn (560293)
Hee Tae Yu (560294)
Jae-Won Jeon (560295)
Hye Sun Lee (501936)
Yangsoo Jang (225494)
Young Woo Park (560296)
Yong-Beom Park (560297)
Eui-Cheol Shin (104030)
Jong-Won Ha (560298)

May 2014

Values are presented as n (%) or mean ± SD. DM, diabetes mellitus; T. chol, Total cholesterol; TG...

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.

L E van der Meeren
J Kluiver
B Rutgers
Y Alsagoor
P M Kluin
A van den Berg
L Visser

January 2019

Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...

The comparison of PD-1 expression in lymph node (LN) and peripheral blood(PB) of patients of DLBCL and peripheral blood(PB) of healthy controls (HC).

Lina Quan (794312)
Xue Chen (127892)
Aichun Liu (794313)
Yan Zhang (8098)
Xiuchen Guo (794314)
Shujie Yan (794315)
Yue Liu (292931)

September 2015

Shown are the expression of PD-1 on CD4+ and CD8+ T cells in LN and PB of a DLBCL patient and a h...

Overall survival of patients with DLBCL based on alterations in MYC, BCL2 and FOXP1.

Carmen Bellas (571304)
Diego García (571305)
Yolanda Vicente (571306)
Linah Kilany (571307)
Victor Abraira (148934)
Belen Navarro (571308)
Mariano Provencio (255839)
Paloma Martín (144198)

June 2014

Kaplan Meier curves represents OS according to A) MYC protein expression, B) FOXP1 protein expres...

Characteristics of subjects from cases and controls.

Lan Chang (456695)
Yunliang Wang (456694)
Huihui Ji (653945)
Dongjun Dai (524764)
Xuting Xu (439173)
Danjie Jiang (395701)
Qingxiao Hong (561669)
Huadan Ye (439172)
Xiaonan Zhang (538829)
Xiaohui Zhou (177941)
Yu Liu (6938)
Jinfeng Li (524762)
Zhongming Chen (135048)
Ying Li (38224)
Dongsheng Zhou (46401)
Renjie Zhuo (653946)
Yuzheng Zhang (102049)
Honglei Yin (653947)
Congcong Mao (653948)
Shiwei Duan (112890)
Qinwen Wang (439170)

November 2014

* p value less than or equal to 0.05 is in bold. a: Log-transformation was used. b: Nonpar...

Biochemical, serological and histological parameters from PBC patients (values are expressed as median and range) according to sCTLA-4 levels (low 0.1–10 ng/ml, and high >10.1 ng/ml).

Daniele Saverino (305573)
Giampaola Pesce (305570)
Princey Antola (585929)
Brunetta Porcelli (657407)
Ignazio Brusca (657408)
Danilo Villalta (444282)
Marilina Tampoia (657409)
Renato Tozzoli (657410)
Elio Tonutti (657411)
Maria Grazia Alessio (657412)
Marcello Bagnasco (305571)
Nicola Bizzaro (444283)

November 2014

Biochemical, serological and histological parameters from PBC patients (values are expressed as m...

Correlation between MTDH expression by immunochemistry analysis and the clinicopathological characteristics of DLBCL patients.

Xueling Ge (154276)
Xiao Lv (154278)
Lili Feng (154280)
Xiaoqian Liu (154284)
Junming Gao (154287)
Na Chen (153323)
Xin Wang (91924)

June 2012

Correlation between MTDH expression by immunochemistry analysis and the clinicopathological chara...

Comparison of CD148, CD45 and LCK expression among NC, MD and SV.

Qinghua Nie (147057)
Erin E. Sandford (147062)
Xiquan Zhang (147066)
Lisa K. Nolan (147070)
Susan J. Lamont (114962)

July 2012

(A) CD148. (B) CD45. (C) LCK. NC, MD and SV stand for the groups of non-challenged, challenged-mi...

Comparison of the Expression and Prognostic Significance of Differentiation Markers between Diffuse Large B-Cell Lymphoma of Central Nervous System Origin and Peripheral Nodal Origin

林璟宏
LIN, CHING-HUNG

October 2009

PURPOSE: Whether diffuse large B-cell lymphoma (DLBCL) of primary central nervous system origin (PCN...

Kaplan-Meier survival analysis of DLBCL patients based on independent CXCR7 protein expression or combined CXCR7 and CXCR4 protein expression.

María José Moreno (5420918)
Alberto Gallardo (1943311)
Silvana Novelli (5420921)
Ana Mozos (5420939)
Marc Aragó (5420927)
Miguel Ángel Pavón (5420936)
María Virtudes Céspedes (5420915)
Víctor Pallarès (5420942)
Aïda Falgàs (5420924)
Miguel Alcoceba (3805117)
Oscar Blanco (2286286)
Marcos Gonzalez-Díaz (5420933)
Jorge Sierra (52100)
Ramon Mangues (5420930)
Isolda Casanova (1800304)

June 2018

(A) Patients bearing CXCR7+ tumors showed significantly higher OS than patients bearing CXCR7- tu...

Patient clinical and immunophenotypical characteristics of patients with DLBCL, NOS in relation to DHS and THS.

Li-Xu Yan (223343)
Yan-Hui Liu (203243)
Dong-Lan Luo (608306)
Fen Zhang (608307)
Yu Cheng (136592)
Xin-Lan Luo (608308)
Jie Xu (34477)
Jie Cheng (294193)
Heng-Guo Zhuang (608309)

August 2014

P values were derived using Pearson’s Chi-Square test. Bold font indicates significance.</...

Comparison of clinicopathological features in DLBCL subgroups.

M. Christina Cox (547731)
Arianna Di Napoli (213516)
Stefania Scarpino (547732)
Gerardo Salerno (455832)
Caterina Tatarelli (547733)
Caterina Talerico (547734)
Mariangela Lombardi (547735)
Bruno Monarca (547736)
Sergio Amadori (13541)
Luigi Ruco (213514)

April 2014

p-value1: comparison of clinical features in IgM-secreting and non-secreting DLBCL sub...

Peripheral blood protein profiling in DLBCL

Ask, E

Quantification of 81 proteins in serum or plasma from 19 healthy blood donors and two cohorts of pat...

Meta-analysis of the association between EBER positivity and clinical features in DLBCL patients.

Xiaojuan Gao (4246837)
Jia Li (160557)
Yaqi Wang (1555240)
Shuai Liu (145969)
Baohong Yue (4246840)

June 2018

(A) number of extranodal involvement(>1 vs ≤1); (B) B symptom(presence vs absence); (C) immunohis...

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas

van der Meeren, L E
Kluiver, J
Rutgers, B
Alsagoor, Y
Kluin, P M
van den Berg, A
Visser, L

October 2019

Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...

Clinical characteristics and laboratory findings of analyzed subjects.

Jong-Chan Youn (560293)
Hee Tae Yu (560294)
Jae-Won Jeon (560295)
Hye Sun Lee (501936)
Yangsoo Jang (225494)
Young Woo Park (560296)
Yong-Beom Park (560297)
Eui-Cheol Shin (104030)
Jong-Won Ha (560298)

May 2014

Values are presented as n (%) or mean ± SD. DM, diabetes mellitus; T. chol, Total cholesterol; TG...

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.

L E van der Meeren
J Kluiver
B Rutgers
Y Alsagoor
P M Kluin
A van den Berg
L Visser

January 2019

Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...

The comparison of PD-1 expression in lymph node (LN) and peripheral blood(PB) of patients of DLBCL and peripheral blood(PB) of healthy controls (HC).

Lina Quan (794312)
Xue Chen (127892)
Aichun Liu (794313)
Yan Zhang (8098)
Xiuchen Guo (794314)
Shujie Yan (794315)
Yue Liu (292931)

September 2015

Shown are the expression of PD-1 on CD4+ and CD8+ T cells in LN and PB of a DLBCL patient and a h...

Overall survival of patients with DLBCL based on alterations in MYC, BCL2 and FOXP1.

Carmen Bellas (571304)
Diego García (571305)
Yolanda Vicente (571306)
Linah Kilany (571307)
Victor Abraira (148934)
Belen Navarro (571308)
Mariano Provencio (255839)
Paloma Martín (144198)

June 2014

Kaplan Meier curves represents OS according to A) MYC protein expression, B) FOXP1 protein expres...

Characteristics of subjects from cases and controls.

Lan Chang (456695)
Yunliang Wang (456694)
Huihui Ji (653945)
Dongjun Dai (524764)
Xuting Xu (439173)
Danjie Jiang (395701)
Qingxiao Hong (561669)
Huadan Ye (439172)
Xiaonan Zhang (538829)
Xiaohui Zhou (177941)
Yu Liu (6938)
Jinfeng Li (524762)
Zhongming Chen (135048)
Ying Li (38224)
Dongsheng Zhou (46401)
Renjie Zhuo (653946)
Yuzheng Zhang (102049)
Honglei Yin (653947)
Congcong Mao (653948)
Shiwei Duan (112890)
Qinwen Wang (439170)

November 2014

* p value less than or equal to 0.05 is in bold. a: Log-transformation was used. b: Nonpar...

Biochemical, serological and histological parameters from PBC patients (values are expressed as median and range) according to sCTLA-4 levels (low 0.1–10 ng/ml, and high >10.1 ng/ml).

Daniele Saverino (305573)
Giampaola Pesce (305570)
Princey Antola (585929)
Brunetta Porcelli (657407)
Ignazio Brusca (657408)
Danilo Villalta (444282)
Marilina Tampoia (657409)
Renato Tozzoli (657410)
Elio Tonutti (657411)
Maria Grazia Alessio (657412)
Marcello Bagnasco (305571)
Nicola Bizzaro (444283)

November 2014

Biochemical, serological and histological parameters from PBC patients (values are expressed as m...

Correlation between MTDH expression by immunochemistry analysis and the clinicopathological characteristics of DLBCL patients.

Xueling Ge (154276)
Xiao Lv (154278)
Lili Feng (154280)
Xiaoqian Liu (154284)
Junming Gao (154287)
Na Chen (153323)
Xin Wang (91924)

June 2012

Correlation between MTDH expression by immunochemistry analysis and the clinicopathological chara...

Comparison of CD148, CD45 and LCK expression among NC, MD and SV.

Qinghua Nie (147057)
Erin E. Sandford (147062)
Xiquan Zhang (147066)
Lisa K. Nolan (147070)
Susan J. Lamont (114962)

July 2012

(A) CD148. (B) CD45. (C) LCK. NC, MD and SV stand for the groups of non-challenged, challenged-mi...

Comparison of the Expression and Prognostic Significance of Differentiation Markers between Diffuse Large B-Cell Lymphoma of Central Nervous System Origin and Peripheral Nodal Origin

林璟宏
LIN, CHING-HUNG

October 2009

PURPOSE: Whether diffuse large B-cell lymphoma (DLBCL) of primary central nervous system origin (PCN...

Kaplan-Meier survival analysis of DLBCL patients based on independent CXCR7 protein expression or combined CXCR7 and CXCR4 protein expression.

María José Moreno (5420918)
Alberto Gallardo (1943311)
Silvana Novelli (5420921)
Ana Mozos (5420939)
Marc Aragó (5420927)
Miguel Ángel Pavón (5420936)
María Virtudes Céspedes (5420915)
Víctor Pallarès (5420942)
Aïda Falgàs (5420924)
Miguel Alcoceba (3805117)
Oscar Blanco (2286286)
Marcos Gonzalez-Díaz (5420933)
Jorge Sierra (52100)
Ramon Mangues (5420930)
Isolda Casanova (1800304)

June 2018

(A) Patients bearing CXCR7+ tumors showed significantly higher OS than patients bearing CXCR7- tu...

Patient clinical and immunophenotypical characteristics of patients with DLBCL, NOS in relation to protein expressions.

Abstract

Extracted data

Patient clinical and immunophenotypical characteristics of patients with DLBCL, NOS in relation to protein expressions.

Abstract

Extracted data

Related items

Related items